Research Keyword: cardiovascular safety

Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis

This comprehensive analysis of 10 clinical trials shows that psilocybin, a compound from magic mushrooms, can rapidly reduce depression symptoms starting within one day of administration and maintain these benefits for up to 6 months. Higher doses and two treatment sessions produced better results than single lower doses. While psilocybin did raise blood pressure temporarily, it was generally well-tolerated with dropout rates similar to placebo.

Read More »

Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder

Researchers tested whether watching nature videos during psilocybin therapy could improve treatment for alcohol addiction. Twenty participants received psilocybin sessions while either watching nature videos or using standard procedures with eyeshades and music. The study found that nature videos significantly reduced the blood pressure increases that normally occur with psilocybin, while maintaining the same therapeutic benefits for reducing alcohol use and promoting meaningful experiences.

Read More »
Scroll to Top